Medical device companies are dealing with the impact ... particularly in life sciences. Bayer's cell therapy for Parkinson's disease is on the brink of a phase 3 trial, while its gene therapy ...

Justice Keogh found for Bayer, noting pelvic pain and abnormal ... The 827-page judgment emphasized that medical devices, which are "inherently dangerous or known to carry a risk of harm," cannot ...

Bayer's two-year-old digital health collaboration ... a personalised digital health programme that combines connected medical devices, biometric analyses such as blood pressure and glucose levels ...

undertaken by Bayer and independent medical researchers, involving more than 270,000 women over the past two decades." But some doctors who have fitted Essure devices remain sceptical. Gynaecology ...